Lisa Yamaguchi-Goto
Chuo, 8608556, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Identifying gene expression predictive of response to neoadjuvant endocrine therapy in early breast cancer.
Journal: Breast cancer research and treatment
Published: February 04, 2025
A progressive and refractory case of breast cancer with Cowden syndrome.
Journal: World journal of surgical oncology
Published: February 18, 2022
Cardiac computed tomography-derived myocardial tissue characterization after anthracycline treatment.
Journal: ESC heart failure
Published: October 26, 2021
Predictive and prognostic significance of BRCAness in HER2-negative breast cancer.
Journal: Breast cancer (Tokyo, Japan)
Published: September 01, 2021
Cardiac computed tomography-derived extracellular volume fraction in late anthracycline-induced cardiotoxicity.
Journal: International journal of cardiology. Heart & vasculature
Published: April 30, 2021
Exosomal miRNA profiles of triple-negative breast cancer in neoadjuvant treatment.
Journal: Oncology letters
Published: January 06, 2021
Analysis of plasma HER2 copy number in cell-free DNA of breast cancer patients: a comparison with HER2 extracellular domain protein level in serum.
Journal: Breast cancer (Tokyo, Japan)
Published: September 17, 2020
Neoadjuvant endocrine therapy for estrogen receptor-positive primary breast cancer.
Journal: Chinese clinical oncology
Published: January 24, 2020
Therapeutic predictors of neoadjuvant endocrine therapy response in estrogen receptor-positive breast cancer with reference to optimal gene expression profiling.
Journal: Breast cancer research and treatment
Published: June 25, 2018
APOBEC3B gene expression as a novel predictive factor for pathological complete response to neoadjuvant chemotherapy in breast cancer.
Journal: Oncotarget
Published: September 24, 2017
Fibroblast growth factor receptor-1 protein expression is associated with prognosis in estrogen receptor-positive/human epidermal growth factor receptor-2-negative primary breast cancer.
Journal: Cancer science
Published: November 12, 2015
Showing 1-11 of 11
Last Updated: 09/26/2026